Safety And Tolerability Of Cael-101, An Anti-Amyloid Monoclonal Antibody, Combined With Anti-Plasma Cell Dyscrasia Therapy In Patients With Light-Chain Amyloidosis: 18-Month Results Of A Phase 2 Study
CAEL-101
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety And Tolerability Of Cael-101, An Anti-Amyloid Monoclonal Antibody, Combined With Anti-Plasma Cell Dyscrasia Therapy In Patients With Light-Chain Amyloidosis: 18-Month Results Of A Phase 2 Study ### Output: CAEL-101